Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 1/20 | 0.51 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.48 |
| ▸ | PTPRB | P23467 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 12/20 | 0.46 |
| ▸ | MMP3 | P08254 | 8/20 | 0.46 |
| ▸ | MMP1 | P03956 | 8/20 | 0.46 |
| ▸ | MMP7 | P09237 | 6/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6796074 | 1.00 | GRIA1 (0.51) | GRIA1PSMB5PTPRBMMP2MMP3 | |
| SCHEMBL6802626 | 0.83 | PTPRB (0.57) | GRIA1PTPRBMMP2MMP3MMP1 | |
| SCHEMBL6802637 | 0.83 | PTPRB (0.57) | GRIA1PTPRBMMP2MMP3MMP1 | |
| SCHEMBL6803291 | 0.83 | PTPRB (0.57) | GRIA1PTPRBMMP2MMP3MMP1 | |
| SCHEMBL8468711 | 0.83 | PSMB5 (0.66) | PSMB5MMP2MMP3MMP1MMP7 | |
| SCHEMBL6803112 | 0.80 | CTSL (0.56) | PTPRBMMP1 | |
| SCHEMBL6807834 | 0.80 | PTPN1 (0.65) | GRIA1 | |
| SCHEMBL6803683 | 0.76 | CTSL (0.54) | PSMB5PTPRB | |
| SCHEMBL6803693 | 0.76 | CTSL (0.54) | PSMB5PTPRB | |
| SCHEMBL6803159 | 0.75 | PTPRB (0.61) | PTPRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004074238-A1 | PHENETHYLAMINO SULFAMIC ACIDS | THE PROCTER & GAMBLE COMPANY (US) | 2004-09-02 | — | — | WO | claimed |
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | claimed |
| WO-2004074238-A1 | PHENETHYLAMINO SULFAMIC ACIDS | THE PROCTER & GAMBLE COMPANY (US) | 2004-09-02 | — | — | WO | disclosed |
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | PTPRM, PTPRS, PTPRE | GRIA1 692/4885PSMB5 672/4885PTPRB 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.